Overview

Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)

Status:
Completed
Trial end date:
2021-01-06
Target enrollment:
Participant gender:
Summary
AZ202001 is a multicenter study of AZR-MD-001 ointment and AZR-MD-001 vehicle in patients with Meibomian Gland Dysfunction (MGD)
Phase:
Phase 2
Details
Lead Sponsor:
Azura Ophthalmics
Collaborators:
Avania
Avania Clinical